Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovari...

Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

When the biggest names on Wall Street make an investment decision, the world listens. As the first quarter of 2024 comes to a close, SEC 13-F filings are coming in hot, showing investors where some...

Johnson & Johnson has a higher credit rating than the U.S. Federal Government. The healthcare giant is in the elite class of Dividend Kings.

The healthcare industry tends to do well in all types of economies. Vertex just garnered a new blockbuster approval, and more could be around the corner.

Johnson & Johnson's business generated modest single-digit growth last quarter. The drugmaker announced it will be raising its dividend for a 62nd consecutive year.

Five stocks to focus with recent dividend hike are: JNJ, TRV, SON, KBH, SPFI.

Bert's March Dividend Income Summary

Altria offers an outsized dividend with little risk of a cut. Johnson & Johnson isn't flashy, but it's a bargain you shouldn't pass up.

An Illinois court late Friday ordered pharmaceutical giant Johnson & Johnson and Kenvue to pay $45 million to a family that alleged the companies' talcum-based baby powder led to the death of a rel...

With continued volatility in the stock market right now, it's no wonder investors are looking for stocks with proven track records to bolster their portfolios. While U.S. stocks opened strong on Mo...

The World Health Organization is likely to issue a wider warning about contaminated Johnson and Johnson-made children's cough syrup found in Nigeria last week, it said in an email.

Johnson & Johnson (NYSE: JNJ) recently reported its Q1 results, with revenues marginally below but earnings exceeding our estimates. The company reported revenue of $21.4 billion and adjusted earni...

A Florida jury on Thursday concluded that Johnson & Johnson's baby powder talc product did not cause the ovarian cancer of a Florida woman who died in 2019.

Johnson & Johnson (J&J) has emphasized the pivotal role of medical technology (MedTech) in advancing healthcare. During a Tuesday (April 16) call with analysts to discuss the first quarter (Q1) and...